Sponsor:
Cytex Therapeutics, Inc.
Code:
NCT06823089
Conditions
Osteoarthritis, Hip
Femoroacetabular Impingement
Osteonecrosis
Trauma Related Injuries
Avascular Necrosis of Bone of Hip
Eligibility Criteria
Sex: All
Age: 14 - 64
Healthy Volunteers: Not accepted
Interventions
ReNew Hip Implant
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-05. This information was provided to ClinicalTrials.gov by Cytex Therapeutics, Inc. on 2025-12-19.